Case number 2021-2121
Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 10, 2023 | 68 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [903478] [MVH] [Entered: 02/10/2023 12:38 PM] (1) |
| Feb 3, 2023 | 67 | ORDER filed denying [57] petition for panel rehearing and rehearing en banc filed by Mylan Pharmaceuticals Inc. By: Per Curiam. Service as of this date by the Clerk of Court. [901839] [MVH] [Entered: 02/03/2023 02:01 PM] (2) |
| Jan 30, 2023 | 66 | Notice from Appellee Merck Sharp & Dohme Corp. Withdrawal of Charles L. McCloud as Counsel. Service: 01/30/2023 by email. [900659] [21-2121] [Jeffrey Lamken] [Entered: 01/30/2023 04:11 PM] (2) |
| Jan 20, 2023 | 65 | 18 paper copies of Doc. No. [64] received from Appellee Merck Sharp & Dohme Corp.. [899271] [VDW] [Entered: 01/24/2023 04:33 PM] (0) |
| Jan 19, 2023 | 64 | RESPONSE of Appellee Merck Sharp & Dohme Corp. to Doc No. [57], [57]. Service: 01/19/2023 by email. [897931] [21-2121] [Jeffrey Lamken] [Entered: 01/19/2023 11:01 AM] (27) |
| Jan 18, 2023 | 63 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Merck Sharp & Dohme Corp., Response to Combined Petition [62], is not in compliance with the rules of this court (see attached). Compliant document due on 01/25/2023. Service as of this date by the Clerk of Court. [897742] [MVH] [Entered: 01/18/2023 03:05 PM] (2) |
| Jan 18, 2023 | 62 | RESPONSE of Appellee Merck Sharp & Dohme Corp. to Doc No. [57], [57]. Service: 01/18/2023 by email. [897710] [21-2121]. This document is non-compliant. See Doc. No. [63] [Jeffrey Lamken] [Entered: 01/18/2023 02:29 PM] (27) |
| Dec 9, 2022 | 61 | ORDER filed granting motion to extend time to file response to rehearing/en banc [60] filed by Appellee Merck Sharp & Dohme Corp. Response to Petition for Rehearing due on or before 01/18/2023. By: Per Curiam. Service as of this date by the Clerk of Court. [889538] [MVH] [Entered: 12/09/2022 09:58 AM] (1) |
| Dec 7, 2022 | 60 | MOTION of Appellee Merck Sharp & Dohme Corp. to extend the time to 01/18/2023 to file brief. Service: 12/07/2022 by email. [889097] [21-2121] [Jeffrey Lamken] [Entered: 12/07/2022 02:40 PM] (10) |
| Dec 5, 2022 | 59 | The court invites a response from Appellee Merck Sharp & Dohme Corp. to the petition [57]. Response due 12/19/2022. Service as of this date by the Clerk of Court. [888412] [MVH] [Entered: 12/05/2022 04:46 PM] (1) |
| Nov 16, 2022 | 58 | 18 paper copies of Doc. No. [57] received from Appellant Mylan Pharmaceuticals Inc.. [884611] [VDW] [Entered: 11/17/2022 09:19 AM] (0) |
| Nov 14, 2022 | 57 | Petition for panel rehearing, for en banc rehearing filed by Appellant Mylan Pharmaceuticals Inc.. Service: 11/14/2022 by email. [884005] [21-2121] [Deepro Mukerjee] [Entered: 11/14/2022 07:50 PM] (41) |
| Oct 27, 2022 | 56 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [55] filed by Appellant Mylan Pharmaceuticals Inc. Petition for Rehearing due on or before 11/14/2022. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [880730] [MVH] [Entered: 10/27/2022 04:07 PM] (2) |
| Oct 25, 2022 | 55 | MOTION of Appellant Mylan Pharmaceuticals Inc. to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 11/14/2022. Service: 10/25/2022 by email. [880177] [21-2121] [Deepro Mukerjee] [Entered: 10/25/2022 02:22 PM] (9) |
| Oct 25, 2022 | 54 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Mylan Pharmaceuticals Inc., Motion for Extension of Time to file a Petition [53], is not in compliance with the rules of this court (see attached). Compliant document due on 11/01/2022. Service as of this date by the Clerk of Court. [880062] [MVH] [Entered: 10/25/2022 09:24 AM] (1) |
| Oct 24, 2022 | 53 | MOTION of Appellant Mylan Pharmaceuticals Inc. to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 11/14/2022. Service: 10/24/2022 by email. [880009] [21-2121]. This document is non-compliant. See Doc. No. [54] [Deepro Mukerjee] [Entered: 10/24/2022 06:58 PM] (8) |
| Oct 24, 2022 | 52 | Amended Certificate of Interest for Appellant Mylan Pharmaceuticals Inc.. Service: 10/24/2022 by email. [880007] [21-2121] [Deepro Mukerjee] [Entered: 10/24/2022 06:49 PM] (4) |
| Oct 24, 2022 | 51 | Amended Entry of Appearance for Deepro Mukerjee;Lance Soderstrom;Jitendra Malik;Eric T. Werlinger as counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 10/24/2022 by email. [880006] [21-2121] [Deepro Mukerjee] [Entered: 10/24/2022 06:47 PM] (3) |
| Oct 2, 2022 | 0 | MYLAN PHARMACEUTICALS INC. v. MERCK SHARP & DOHME CORP. [OPINION] [precedential] (0) |
| Sep 29, 2022 | 50 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [874621] [MJL] [Entered: 09/29/2022 08:33 AM] (1) |
| Sep 29, 2022 | 49 | OPINION filed for the court by Lourie, Circuit Judge; Reyna, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [874620] [MJL] [Entered: 09/29/2022 08:32 AM] (15) |
| Aug 2, 2022 | 48 | Submitted after ORAL ARGUMENT to Panel: Lourie, Circuit Judge; Reyna, Circuit Judge and Stoll, Circuit Judge.Arguing counsel: Eric Thomas Werlinger for Mylan Pharmaceuticals Inc. and Jeffrey A. Lamken for Merck Sharp & Dohme Corp.Oral Argument Audio available here. [864298] [MJL] [Entered: 08/02/2022 11:41 AM] (0) |
| Jul 1, 2022 | 47 | Response to notice of oral argument from Appellee Merck Sharp & Dohme Corp.. Service: 07/01/2022 by email. [858849] [21-2121] [Jeffrey Lamken] [Entered: 07/01/2022 03:29 PM] (3) |
| Jul 1, 2022 | 46 | Response to notice of oral argument from Appellant Mylan Pharmaceuticals Inc.. Service: 07/01/2022 by email. [858842] [21-2121] [Eric Werlinger] [Entered: 07/01/2022 03:12 PM] (3) |
| Jun 17, 2022 | 45 | NOTICE OF ORAL ARGUMENT. Panel: 2208B. Case scheduled August 2, 2022. Response to Notice of Oral Argument due: 07/01/2022. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [856283] [JCP] [Entered: 06/17/2022 03:43 PM] (2) |
| May 12, 2022 | 44 | The following conflict dates submitted by Jeffrey A. Lamken for Merck Sharp & Dohme Corp. have been accepted by the court: 07/05/2022, 07/06/2022, 07/07/2022, 07/08/2022. [849337] [MJL] [Entered: 05/12/2022 08:21 AM] (0) |
| May 11, 2022 | 43 | Notice from Appellee Merck Sharp & Dohme Corp. regarding conflicts with oral argument. Service: 05/11/2022 by email. [849319] [21-2121] [Jeffrey Lamken] [Entered: 05/11/2022 06:26 PM] (2) |
| May 9, 2022 | 42 | Notice from Appellee Merck Sharp & Dohme Corp. regarding conflicts with oral argument. Service: 05/09/2022 by email. [848558] [21-2121] [Jeffrey Lamken] [Entered: 05/09/2022 02:51 PM] (2) |
| May 3, 2022 | 41 | Amended Entry of appearance for Bruce R. Genderson; Stanley E. Fisher; David M. Krinsky; Charles L. McCloud; Shaun P. Mahaffy as counsel for Appellee Merck Sharp & Dohme Corp.. Service: 05/03/2022 by email. [847351] [21-2121] [Jeffrey Lamken] [Entered: 05/03/2022 07:48 PM] (2) |
| Apr 8, 2022 | 40 | The following conflict dates submitted by Deepro Mukerjee for Mylan Pharmaceuticals Inc. have been accepted by the court: 06/06/2022, 06/07/2022, 06/08/2022, 06/09/2022, 06/10/2022, 08/04/2022, 08/05/2022, 10/05/2022, 10/06/2022, 10/07/2022. [841930] [MJL] [Entered: 04/08/2022 11:26 AM] (0) |
| Apr 5, 2022 | 37 | Notice from Appellee Merck Sharp & Dohme Corp. regarding conflicts with oral argument. Service: 04/05/2022 by email. [841224] [21-2121] [Jeffrey Lamken] [Entered: 04/05/2022 05:53 PM] (1) |
| Apr 5, 2022 | 36 | Notice from Appellant Mylan Pharmaceuticals Inc. regarding conflicts with oral argument. Service: 04/05/2022 by email. [841187] [21-2121] [Deepro Mukerjee] [Entered: 04/05/2022 03:30 PM] (2) |
| Apr 4, 2022 | 39 | 6 paper copies of Doc. No. [28] received from Appellee Merck Sharp & Dohme Corp.. [841885] [VDW] [Entered: 04/08/2022 10:25 AM] (0) |
| Apr 1, 2022 | 38 | 6 paper copies of Doc. No. [32], [31], [24] received from Appellant Mylan Pharmaceuticals Inc.. [841254] [VDW] [Entered: 04/06/2022 08:41 AM] (0) |
| Mar 29, 2022 | 35 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [839586] [JCW] [Entered: 03/29/2022 09:07 AM] (1) |
| Mar 29, 2022 | 34 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [839585] [JCW] [Entered: 03/29/2022 09:06 AM] (0) |
| Mar 28, 2022 | 33 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Mylan Pharmaceuticals Inc. and Appellee Merck Sharp & Dohme Corp.. Service: 03/28/2022 by email. [839501] [21-2121] [Deepro Mukerjee] [Entered: 03/28/2022 06:49 PM] (3) |
| Mar 28, 2022 | 32 | MODIFIED ENTRY: APPENDIX FILED by Appellant Mylan Pharmaceuticals Inc.. Service: 03/28/2022 by email. [839499] --[Edited 03/29/2022 by JCW - compliance review complete] [Deepro Mukerjee] [Entered: 03/28/2022 06:46 PM] (1054) |
| Mar 21, 2022 | 31 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Mylan Pharmaceuticals Inc.. Service: 03/21/2022 by email. [838104] --[Edited 03/22/2022 by JCW - compliance review complete] [Deepro Mukerjee] [Entered: 03/21/2022 05:13 PM] (32) |
| Feb 7, 2022 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file brief [29] filed by Appellant Mylan Pharmaceuticals Inc.. The reply brief is due 03/21/2022.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [829246] [JCW] [Entered: 02/07/2022 09:09 AM] (0) |
| Feb 4, 2022 | 29 | MOTION of Appellant Mylan Pharmaceuticals Inc. to extend the time to 03/21/2022 to file brief. Service: 02/04/2022 by email. [829171] [21-2121] [Eric Werlinger] [Entered: 02/04/2022 05:00 PM] (12) |
| Jan 28, 2022 | 28 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Merck Sharp & Dohme Corp. Service: 01/28/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [827832] --[Edited 01/31/2022 by JCW -compliance review complete] [Mark Kelley] [Entered: 01/28/2022 06:24 PM] (80) |
| Jan 28, 2022 | 27 | Entry of appearance for Mark W. Kelley as counsel for Appellee Merck Sharp & Dohme Corp.. Service: 01/28/2022 by email. [827831] [21-2121] [Mark Kelley] [Entered: 01/28/2022 06:18 PM] (1) |
| Nov 16, 2021 | 26 | **TEXT ONLY** ORDER granting motion to extend time to file brief [25] filed by Appellee Merck Sharp & Dohme Corp. The response brief is due 01/28/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [812593] [JCW] [Entered: 11/16/2021 09:33 AM] (0) |
| Nov 15, 2021 | 25 | MOTION of Appellee Merck Sharp & Dohme Corp. to extend the time to 01/28/2022 to file brief. Service: 11/15/2021 by email. [812529] [21-2121] [Jeffrey Lamken] [Entered: 11/15/2021 08:40 PM] (10) |
| Oct 18, 2021 | 24 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Mylan Pharmaceuticals Inc. Service: 10/18/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [806588] --[Edited 10/19/2021 by JCW - compliance review complete] [Deepro Mukerjee] [Entered: 10/18/2021 06:37 PM] (173) |
| Oct 18, 2021 | 23 | Amended Certificate of Interest for Appellant Mylan Pharmaceuticals Inc.. Service: 10/18/2021 by email. [806574] [21-2121] [Deepro Mukerjee] [Entered: 10/18/2021 05:11 PM] (4) |
| Oct 18, 2021 | 22 | ORDER granting [20] [21] the motions.; Appeal Nos. 2021-2122 and 2021-2123 are dismissed. Sun Pharmaceuticals is withdrawn as a party from Appeal Nos. 2021-2121, -2122, and Dr. Reddy's is withdrawn as a party from Appeal Nos. 2021-2121, -2123. The revised official caption is reflected above. Each side shall bear its own costs as to Appeal Nos. 2021-2122 and 2021-2123.; issuing mandate (as to 2021-2122, 2021-2123 only). Service as of this date by the Clerk of Court. [806458] [21-2121, 21-2122, 21-2123] [LMS] [Entered: 10/18/2021 02:11 PM] (3) |
| Oct 12, 2021 | 21 | MOTION of Appellants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. to withdraw party, Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., as a party to this appeal. Service: 10/12/2021 by email. [805077] [21-2121] [Russell Faegenburg] [Entered: 10/12/2021 04:01 PM] (7) |
| Oct 4, 2021 | 20 | MOTION of Appellant Sun Pharmaceuticals Industries Ltd. to withdraw party, Sun Pharmaceuticals Industries Ltd., as a party to this appeal. Service: 10/04/2021 by email. [803525] [21-2121] [Jovial Wong] [Entered: 10/04/2021 06:22 PM] (7) |
| Aug 18, 2021 | 19 | Certified list received. Service: 08/18/2021 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [793755] [21-2121, 21-2122, 21-2123] [JCW] [Entered: 08/18/2021 03:06 PM] (83) |
| Jul 27, 2021 | 18 | Corrected Entry of appearance for Tedd Van Buskirk; Russell W. Faegenburg as counsel for Appellants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 07/27/2021 by email. [788913] [21-2121] [Tedd Van Buskirk] [Entered: 07/27/2021 11:47 AM] (1) |
| Jul 23, 2021 | 17 | Docketing Statement for the Appellant Sun Pharmaceuticals Industries Ltd.. Service: 07/23/2021 by email. [788446] [21-2121] [Jovial Wong] [Entered: 07/23/2021 03:41 PM] (3) |
| Jul 23, 2021 | 16 | Certificate of Interest for Appellant Sun Pharmaceuticals Industries Ltd.. Service: 07/23/2021 by email. [788437] [21-2121] [Jovial Wong] [Entered: 07/23/2021 03:31 PM] (4) |
| Jul 23, 2021 | 15 | Entry of appearance for Jovial Wong: Charles B. Klein as counsel for Appellant Sun Pharmaceuticals Industries Ltd.. Service: 07/23/2021 by email. [788428] [21-2121] [Jovial Wong] [Entered: 07/23/2021 03:18 PM] (1) |
| Jul 23, 2021 | 14 | Docketing Statement for the Appellant Mylan Pharmaceuticals Inc.. Service: 07/23/2021 by email. [788426] [21-2121] [Deepro Mukerjee] [Entered: 07/23/2021 03:17 PM] (4) |
| Jul 23, 2021 | 13 | Certificate of Interest for Appellant Mylan Pharmaceuticals Inc.. Service: 07/23/2021 by email. [788421] [21-2121] [Deepro Mukerjee] [Entered: 07/23/2021 03:15 PM] (4) |
| Jul 23, 2021 | 12 | Entry of appearance for Deepro Mukerjee; Jitendra Malik; Lance Soderstrom; Eric T. Werlinger as counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 07/23/2021 by email. [788417] [21-2121] [Deepro Mukerjee] [Entered: 07/23/2021 03:12 PM] (3) |
| Jul 23, 2021 | 11 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [8], Doc No. [9], Doc No. [10], ERROR: Appellee's filings do not include all consolidated case numbers. CORRECTION: Future filings must list all consolidated case numbers (21-2121, 21-2122, 21-2123). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [788319] [JCW] [Entered: 07/23/2021 11:30 AM] (0) |
| Jul 23, 2021 | 10 | Certificate of Interest for Appellee Merck Sharp & Dohme Corp.. Service: 07/23/2021 by email. [788311] [21-2121] [Jeffrey Lamken] [Entered: 07/23/2021 11:12 AM] (3) |
| Jul 23, 2021 | 9 | Docketing Statement for the Appellee Merck Sharp & Dohme Corp.. Service: 07/23/2021 by email. [788309] [21-2121] [Jeffrey Lamken] [Entered: 07/23/2021 11:11 AM] (2) |
| Jul 23, 2021 | 8 | Entry of appearance for Jeffrey A. Lamken; Michael G. Pattillo, Jr.; Caleb Hayes-Deats; Lauren F. Dayton; Bruce R. Genderson; Stanley E. Fisher; David M. Krinsky; Charles L. McCloud; Shaun P. Mahaffy. as counsel for Appellee Merck Sharp & Dohme Corp.. Service: 07/23/2021 by email. [788307] [21-2121] [Jeffrey Lamken] [Entered: 07/23/2021 11:09 AM] (3) |
| Jul 23, 2021 | 7 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., Entry of Appearance [4], is not in compliance with the rules of this court (see attached). Compliant document due on 07/30/2021. Service as of this date by the Clerk of Court. [788286] [JCW] [Entered: 07/23/2021 10:20 AM] (1) |
| Jul 22, 2021 | 6 | Docketing Statement for the Appellants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 07/22/2021 by email. [788171] [21-2121] [Tedd Van Buskirk] [Entered: 07/22/2021 05:34 PM] (3) |
| Jul 22, 2021 | 5 | Certificate of Interest for Appellants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 07/22/2021 by email. [788170] [21-2121] [Tedd Van Buskirk] [Entered: 07/22/2021 05:32 PM] (3) |
| Jul 22, 2021 | 4 | Entry of appearance for Russell W. Faegenburg; Tedd W. Van Buskirk as counsel for Appellants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 07/22/2021 by email. [788168] [21-2121]. This document is non-compliant. See Doc No. [7] [Tedd Van Buskirk] [Entered: 07/22/2021 05:31 PM] (1) |
| Jul 20, 2021 | 3 | Note to File: The following cases are consolidated: 21-2121 Lead with 21-2122 and 21-2123 Member Cases. The parties must file all documents in the lead appeal only. [787401] [21-2121, 21-2122, 21-2123] [JCW] [Entered: 07/20/2021 03:27 PM] (0) |
| Jul 20, 2021 | 2 | ORDER consolidating appeals (21-2121, 21-2122, 21-2123). The Certified Lists are due no later than August 18, 2021. Service as of this date by the Clerk of Court. [787392] [21-2121, 21-2122, 21-2123] [JCW] [Entered: 07/20/2021 03:18 PM] (2) |
| Jul 9, 2021 | 1 | Appeal docketed. Received: 07/08/2021. [785165] Entry of Appearance is due on 07/23/2021. Certificate of Interest is due on 07/23/2021. Docketing Statement is due on 07/23/2021. Certified List is due on 08/18/2021. [JCW] [Entered: 07/09/2021 09:02 AM] (0) |
